BridGene Biosciences is a biotechnology company focusing on discovering and developing innovative small molecules that drug high value yet previously undruggable targets, providing new paths to treat diseases.
Currently, about 90% of proteins associated with diseases cannot be targeted by traditional therapies due to the lack of a known addressable binding site. BridGene intends to change this by using its proprietary Chemo...
BridGene Biosciences is a biotechnology company focusing on discovering and developing innovative small molecules that drug high value yet previously undruggable targets, providing new paths to treat diseases.
Currently, about 90% of proteins associated with diseases cannot be targeted by traditional therapies due to the lack of a known addressable binding site. BridGene intends to change this by using its proprietary Chemoproteomics platform, IMTAC™ (Isobaric Mass Tagged Affinity Characterization).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.